🧪 Experiments

5 proposed experiments from the Forge — designed to validate, falsify, and explore hypotheses

5
Total Experiments
0.71
Avg Score
0.52
Avg Feasibility
171
Clinical
202
Validation
27
Falsification
All Types animal_model (7)cell_biology (8)clinical (171)computational (12)exploratory (242)falsification (27)gene_expression (6)genetic_association (16)in-vitro (4)in_vitro (2)in-vivo (5)in_vivo (8)neuropathology (14)validation (202)
Sort by: ScoreFeasibilityNoveltyCostNewest
in-vivo 0.85
Plasma p-tau217-Triggered Exosome Dosing Maximizes lncRNA-0021 Therapeutic Window
🧬 N/A 🏥 Alzheimer disease
💰 $44,000 ⏱ 11mo ✅ 0.78 ✨ 0.80
in-vivo
Expected: P-tau217-stratified dosing reduces amyloid and tau pathology by >30% and improves cognitive performa...
in-vivo 0.85
Theta-Gamma Coupling Restoration Through PV Interneuron Optogenetic Modulation
🧬 N/A 🏥 Alzheimer disease
💰 $50,000 ⏱ 12mo ✅ 0.78 ✨ 0.80
in-vivo
Expected: Closed-loop stimulation restores theta-gamma coupling (phase-amplitude coupling index restored to >8...
in-vivo 0.85
SCFA-GPR43-TREM2 Axis in Microglial Homeostasis Using Germ-Free Mouse Model
🧬 N/A 🏥 Alzheimer disease
💰 $38,000 ⏱ 10mo ✅ 0.78 ✨ 0.80
in-vivo
Expected: SCFA supplementation increases TREM2 expression and reduces amyloid plaque load by >30% in germ-free...
in-vivo 0.85
Vagus Nerve Alpha-Synuclein Propagation and Brainstem Involvement in PD
🧬 N/A 🏥 Parkinson disease
💰 $42,000 ⏱ 14mo ✅ 0.78 ✨ 0.80
in-vivo
Expected: Vagotomized mice show >50% reduction in p-Syn (Ser129) pathology in the ipsilateral DMV and demonstr...
in-vivo 0.85
Enteric Alpha-Synuclein Propagation and ENS Dysfunction in PD Mouse Model
🧬 N/A 🏥 Parkinson disease
💰 $48,000 ⏱ 12mo ✅ 0.78 ✨ 0.80
in-vivo
Expected: Alpha-synuclein pathology detected in vagus nerve and dorsal motor nucleus by 6 months post-injectio...
All 5 experiments loaded